Insider Transactions last 24 months for Crinetics Pharmaceuticals, Inc.  -  NSDQ: CRNX

 
Transactions
All Buy Sell Option Exercise
Filer's Name
Relationship/
Title
Trans.
Date
Trans. Type
Ownership Type
Security Type
Shares
Price
Trans.
Value
Total Shares Owned
Struthers Richard ScottPresident & CEO03/16/2026DSDirectCOM8,785$37.77$331,809.45404,778
Struthers Richard ScottPresident & CEO03/16/2026DSDirectCOM13,196$37.11$489,703.56413,563
Betz Stephen F.Chief Scientific Officer03/16/2026DSDirectCOM4,241$37.77$160,182.57137,101
Betz Stephen F.Chief Scientific Officer03/16/2026DSDirectCOM6,371$37.11$236,427.81141,342
Knight Jeff E.Chief Operating Officer03/16/2026DSDirectCOM3,961$37.77$149,606.97112,018
Knight Jeff E.Chief Operating Officer03/16/2026DSDirectCOM5,950$37.11$220,804.50115,979
Vivaldi Coelho RogerioDirector03/12/2026DSDirectCOM523$36.77$19,230.7116,300
Vivaldi Coelho RogerioDirector03/12/2026DSDirectCOM4,477$36.08$161,530.1616,823
Schilke TobinChief Financial Officer03/03/2026DSDirectCOM6,713$39.67$266,304.7178,121
Okey StephanieDirector03/03/2026DSDirectCOM3,000$39.67$119,010.0013,300
Kalofonos IsabelChief Commercial Officer02/23/2026AADirectCOM34,000$0.00$0.0034,834
Betz Stephen F.Chief Scientific Officer02/23/2026AADirectCOM30,000$0.00$0.00147,713
Knight Jeff E.Chief Operating Officer02/23/2026AADirectCOM34,000$0.00$0.00121,929
Schilke TobinChief Financial Officer02/23/2026AADirectCOM32,000$0.00$0.0084,834
Struthers Richard ScottPresident & CEO02/23/2026AADirectCOM62,000$0.00$0.00426,759
Kalofonos IsabelChief Commercial Officer01/05/2026DSDirectCOM2,500$55.00$137,500.00834
Kalofonos IsabelChief Commercial Officer01/05/2026AMDirectCOM2,500$40.59$101,475.003,334
Betz Stephen F.Chief Scientific Officer12/26/2025AMDirectCOM18,000$1.91$34,380.00117,713
Struthers Richard ScottPresident & CEO12/18/2025AMDirectCOM28,400$15.29$434,236.00364,759
Struthers Richard ScottPresident & CEO12/18/2025AMDirectCOM16,342$9.28$151,653.76336,359
Pizzuti DanaChief Med and Dev Officer12/01/2025DSDirectCOM5,000$45.02$225,100.0066,837
Pizzuti DanaChief Med and Dev Officer12/01/2025AMDirectCOM5,000$16.89$84,450.0071,837
Pizzuti DanaChief Med and Dev Officer11/03/2025DSDirectCOM100$43.27$4,327.0066,270
Pizzuti DanaChief Med and Dev Officer11/03/2025DSDirectCOM4,900$42.65$208,985.0066,370
Pizzuti DanaChief Med and Dev Officer11/03/2025AMDirectCOM5,000$16.89$84,450.0071,270
1   2  3  4  5  Next Last  You are at page 1 of 5 pages
Transaction Type Key
First letter: A = Acquired, D = Disposed
Second letter:
A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust 		Export Table Data to Excel Send to Excel